125 related articles for article (PubMed ID: 36256885)
1. The Antipsychotic Dopamine 2 Receptor Antagonist Diphenylbutylpiperidines Improve Glycemia in Experimental Obesity by Inhibiting Succinyl-CoA:3-Ketoacid CoA Transferase.
Tabatabaei Dakhili SA; Greenwell AA; Yang K; Abou Farraj R; Saed CT; Gopal K; Chan JSF; Chahade JJ; Eaton F; Lee C; Velázquez-Martínez CA; Crawford PA; Glover JNM; Al Batran R; Ussher JR
Diabetes; 2023 Jan; 72(1):126-134. PubMed ID: 36256885
[TBL] [Abstract][Full Text] [Related]
2. Pimozide Alleviates Hyperglycemia in Diet-Induced Obesity by Inhibiting Skeletal Muscle Ketone Oxidation.
Al Batran R; Gopal K; Capozzi ME; Chahade JJ; Saleme B; Tabatabaei-Dakhili SA; Greenwell AA; Niu J; Almutairi M; Byrne NJ; Masson G; Kim R; Eaton F; Mulvihill EE; Garneau L; Masters AR; Desta Z; Velázquez-Martínez CA; Aguer C; Crawford PA; Sutendra G; Campbell JE; Dyck JRB; Ussher JR
Cell Metab; 2020 May; 31(5):909-919.e8. PubMed ID: 32275862
[TBL] [Abstract][Full Text] [Related]
3. Comment on Tabatabaei Dakhili et al. The Antipsychotic Dopamine 2 Receptor Antagonist Diphenylbutylpiperidines Improve Glycemia in Experimental Obesity by Inhibiting Succinyl-CoA:3-Ketoacid CoA Transferase. Diabetes 2023;72:126-134.
Reynolds GP
Diabetes; 2023 May; 72(5):e5. PubMed ID: 37146278
[No Abstract] [Full Text] [Related]
4. Blockade of low and high threshold Ca2+ channels by diphenylbutylpiperidine antipsychotics linked to inhibition of prolactin gene expression.
Enyeart JJ; Biagi BA; Day RN; Sheu SS; Maurer RA
J Biol Chem; 1990 Sep; 265(27):16373-9. PubMed ID: 1697857
[TBL] [Abstract][Full Text] [Related]
5. Ketone ester administration improves glycemia in obese mice.
Tabatabaei Dakhili SA; Yang K; Locatelli CAA; Saed CT; Greenwell AA; Chan JSF; Chahade JJ; Scharff J; Al-Imarah S; Eaton F; Crawford PA; Gopal K; Mulvihill EE; Ussher JR
Am J Physiol Cell Physiol; 2023 Sep; 325(3):C750-C757. PubMed ID: 37575059
[TBL] [Abstract][Full Text] [Related]
6. Receptors for diphenylbutylpiperidine neuroleptics in brain, cardiac, and smooth muscle membranes. Relationship with receptors for 1,4-dihydropyridines and phenylalkylamines and with Ca2+ channel blockade.
Qar J; Galizzi JP; Fosset M; Lazdunski M
Eur J Pharmacol; 1987 Sep; 141(2):261-8. PubMed ID: 2445589
[TBL] [Abstract][Full Text] [Related]
7. Dual pharmacological properties of a cyclic AMP-sensitive potassium channel.
Gomora JC; Enyeart JJ
J Pharmacol Exp Ther; 1999 Jul; 290(1):266-75. PubMed ID: 10381786
[TBL] [Abstract][Full Text] [Related]
8. Preferential block of T-type calcium channels by neuroleptics in neural crest-derived rat and human C cell lines.
Enyeart JJ; Biagi BA; Mlinar B
Mol Pharmacol; 1992 Aug; 42(2):364-72. PubMed ID: 1355264
[TBL] [Abstract][Full Text] [Related]
9. Antipsychotic pimozide is a potent Ca2+ channel blocker in heart.
Enyeart JJ; Dirksen RT; Sharma VK; Williford DJ; Sheu SS
Mol Pharmacol; 1990 May; 37(5):752-7. PubMed ID: 2160063
[TBL] [Abstract][Full Text] [Related]
10. Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice.
Dandawate P; Kaushik G; Ghosh C; Standing D; Ali Sayed AA; Choudhury S; Subramaniam D; Manzardo A; Banerjee T; Santra S; Ramamoorthy P; Butler M; Padhye SB; Baranda J; Kasi A; Sun W; Tawfik O; Coppola D; Malafa M; Umar S; Soares MJ; Saha S; Weir SJ; Dhar A; Jensen RA; Thomas SM; Anant S
Gastroenterology; 2020 Apr; 158(5):1433-1449.e27. PubMed ID: 31786131
[TBL] [Abstract][Full Text] [Related]
11. Lower succinyl-CoA:3-ketoacid-CoA transferase (SCOT) and ATP citrate lyase in pancreatic islets of a rat model of type 2 diabetes: knockdown of SCOT inhibits insulin release in rat insulinoma cells.
Hasan NM; Longacre MJ; Seed Ahmed M; Kendrick MA; Gu H; Ostenson CG; Fukao T; MacDonald MJ
Arch Biochem Biophys; 2010 Jul; 499(1-2):62-8. PubMed ID: 20460097
[TBL] [Abstract][Full Text] [Related]
12. Identification of the cysteine residue exposed by the conformational change in pig heart succinyl-CoA:3-ketoacid coenzyme A transferase on binding coenzyme A.
Tammam SD; Rochet JC; Fraser ME
Biochemistry; 2007 Sep; 46(38):10852-63. PubMed ID: 17718512
[TBL] [Abstract][Full Text] [Related]
13. A structural mapping of mutations causing succinyl-CoA:3-ketoacid CoA transferase (SCOT) deficiency.
Shafqat N; Kavanagh KL; Sass JO; Christensen E; Fukao T; Lee WH; Oppermann U; Yue WW
J Inherit Metab Dis; 2013 Nov; 36(6):983-7. PubMed ID: 23420214
[TBL] [Abstract][Full Text] [Related]
14. Stable expression and characterization of the human brain potassium channel Kv2.1: blockade by antipsychotic agents.
Wible B; Murawsky MK; Crumb WJ; Rampe D
Brain Res; 1997 Jun; 761(1):42-50. PubMed ID: 9247064
[TBL] [Abstract][Full Text] [Related]
15. Structure of succinyl-CoA:3-ketoacid CoA transferase from Drosophila melanogaster.
Zhang M; Xu HY; Wang YC; Shi ZB; Zhang NN
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2013 Oct; 69(Pt 10):1089-93. PubMed ID: 24100554
[TBL] [Abstract][Full Text] [Related]
16. Antischizophrenic drugs of the diphenylbutylpiperidine type act as calcium channel antagonists.
Gould RJ; Murphy KM; Reynolds IJ; Snyder SH
Proc Natl Acad Sci U S A; 1983 Aug; 80(16):5122-5. PubMed ID: 6136040
[TBL] [Abstract][Full Text] [Related]
17. Succinyl-CoA:3-ketoacid coenzyme A transferase (SCOT): development of an antibody to human SCOT and diagnostic use in hereditary SCOT deficiency.
Song XQ; Fukao T; Mitchell GA; Kassovska-Bratinova S; Ugarte M; Wanders RJ; Hirayama K; Shintaku H; Churchill P; Watanabe H; Orii T; Kondo N
Biochim Biophys Acta; 1997 Apr; 1360(2):151-6. PubMed ID: 9128180
[TBL] [Abstract][Full Text] [Related]
18. Enzymes of ketone body utilization in human tissues: protein and messenger RNA levels of succinyl-coenzyme A (CoA):3-ketoacid CoA transferase and mitochondrial and cytosolic acetoacetyl-CoA thiolases.
Fukao T; Song XQ; Mitchell GA; Yamaguchi S; Sukegawa K; Orii T; Kondo N
Pediatr Res; 1997 Oct; 42(4):498-502. PubMed ID: 9380443
[TBL] [Abstract][Full Text] [Related]
19. Successful adaptation to ketosis by mice with tissue-specific deficiency of ketone body oxidation.
Cotter DG; Schugar RC; Wentz AE; d'Avignon DA; Crawford PA
Am J Physiol Endocrinol Metab; 2013 Feb; 304(4):E363-74. PubMed ID: 23233542
[TBL] [Abstract][Full Text] [Related]
20. A neonatal-onset succinyl-CoA:3-ketoacid CoA transferase (SCOT)-deficient patient with T435N and c.658-666dupAACGTGATT p.N220_I222dup mutations in the OXCT1 gene.
Fukao T; Ishii T; Amano N; Kursula P; Takayanagi M; Murase K; Sakaguchi N; Kondo N; Hasegawa T
J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S307-13. PubMed ID: 20652411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
